JAK2 and myeloproliferative neoplasm: However, recent reports of PNH arising in the setting of a CALR-mutated MPN [50],CML [51] and a relapse of AML associated with TET2 and JAK2 mutations [52] raise the question of whether autoimmunity is necessary in all cases.